|
|
 |
Employee
|
Welcome to the Public Employees' Benefits Program _________________________________________________________ Frequently Asked Questions _________________________________________________________
The Nevada State Health Division has posted important information about the Catalyst Rx has provided information on the recall of H1N1 vaccines. This recall was issued following the discovery that these four lots no longer met the manufacturer’s potency specifications. The Centers for Disease Control and Prevention (CDC) has indicated that there are no safety concerns associated with this recall. Please note that since this recall is not yet classified, is lot-specific, and as the H1N1 vaccine is not typically distributed through a prescription, member and physician notifications will not be conducted. To read about the recall, click here. O n December 22, 2009, MedImmune recalled 13 lots of its nasal spray influenza A (H1N1) vaccine after a routine stability test did not meet potency standards and indicated a slight decrease of potency of the H1N1 component of the vaccine. MedImmune has stated that there are no safety concerns with these 13 lots of H1N1 vaccine and all lots successfully passed pre-release testing for safety, purity and potency. This recall is limited to the nasal spray formulation of the H1N1 vaccine. To read more about this recall, click here.
There is an Rx Update discussing the voluntary recall of all lots of Tylenol Arthritis Pain Caplet 100-count bottles with a red EZ-Open cap. This is an expansion of a limited recall previously announced. The recall was expanded as a precaution due to consumer reports of an unusual moldy, musty or mildew-like odor that was associated with nausea, stomach pain, vomiting and diarrhea. To read details on the recall, click here. January 15, 2010, McNeil Consumer Healthcare announced an expansion of the voluntary recall of certain lots of various over-the-counter (OTC) products. This is an expansion of a prior recall of all lots of Tylenol® Arthritis Pain 100 count with EZ Open Caps in December 2009. The recall is being expanded as a precaution due to consumer reports of unusual moldy, musty or mildew-like odor that was associated with nausea, stomach pain, vomiting and diarrhea. This expanded recall impacts an additional 54 million bottles of McNeil Consumer Healthcare products to the initial recall, bringing the total recall to over 60 million bottles. The recall impacts over 27 McNeil Consumer Healthcare products in various packages and quantities. For more information, click here.
_________________________________________________________ Master Plan Document Plan Year 2010 _________________________________________________________ Live Well, Be Well View the PPO Wellness flyer with Preventive Care Guidelines Cardiac Wellness Pilot Program _________________________________________________________ Our office is located in the Richard H. Bryan Building. 901 South Stewart Street, Suite 1001 (775) 684-7000 or (800) 326-5496
|
|||
| Home Site Map Search Privacy Notice Comments and Questions |
